OrthoPediatrics Corp. Receives FDA approval for 3P™ Pediatric Plating Platform™ Small-Mini System, the second of several systems in the 3P family

Impact · against what's priced in

OrthoPediatrics gains a modest catalyst from the FDA approval of the 3P Small-Mini System, expanding its pediatric plating portfolio. While the approval was received ahead of expectations, the actual revenue contribution is deferred until the limited market release in early 2026.

KIDS+0.40

No priced-in read yet